I just bought into NUWE after seeing the substantial buying volume and the forecast for a 3x revenue increase. With their new payment structure and a strong pediatric segment growing, I think this stock could be drastically undervalued and worth over $3/share in the near future.

With NUWE jumping 60-99% in premarket, there's clearly some strong momentum building. The recent news about the increased reimbursement rate adds to my conviction that this stock is set for further gains, making it a perfect candidate for a swing trade.

I'm really excited about $NUWE right now. With a small float and the upcoming presentation of new clinical evidence for their Aquadex therapy at a major conference, I see a real opportunity for a squeeze. Despite past highs and lows, I believe the market is underestimating this stock's potential for recovery.